LGALS9 and cancer: Anti-Cancer T cells have ‘brakes’ (called checkpoints) on their activities in the form of membranous proteins such as PD-1 and TIM-3; when PD-L1 (or Gal-9) combines with PD-1 (or TIM-3) the T cell activation is inhibited.